These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18663272)

  • 1. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
    Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
    Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].
    Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis type 1: a survey of 195 patients].
    Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 1 in childhood].
    Kongshaug N; Meyer B; Kolmannskog S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(18):2653-7. PubMed ID: 10479978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical diagnosis of neurofibromatosis type 1].
    Wolkenstein P; Zeller J
    Presse Med; 1999 Dec; 28(39):2174-80. PubMed ID: 10629698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical study of type 1 neurofibromatosis in north west England.
    McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
    J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic outcome in children with multiple café au lait spots.
    Korf BR
    Pediatrics; 1992 Dec; 90(6):924-7. PubMed ID: 1344978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].
    Karwacki MW; Woźniak W
    Med Wieku Rozwoj; 2006; 10(3 Pt 2):923-48. PubMed ID: 17401183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotypic and genetic features in neurofibromatosis type 1 in children].
    Duat Rodríguez A; Martos Moreno GÁ; Martín Santo-Domingo Y; Hernández Martín A; Espejo-Saavedra Roca JM; Ruiz-Falcó Rojas ML; Argente J
    An Pediatr (Barc); 2015 Sep; 83(3):173-82. PubMed ID: 25541118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anxiety disorders in type 1 neurofibromatosis: A case report].
    Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
    Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye disorders in neurofibromatosis (NF1).
    Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
    Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic significance of unilateral Lisch nodules.
    Ceuterick SD; Van Den Ende JJ; Smets RM
    Bull Soc Belge Ophtalmol; 2005; (295):49-53. PubMed ID: 15849989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
    Friedrich RE; Hartmann M; Mautner VF
    Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.